GlassScriptPhysician profile
Joseph C Beck
NPI 1386682144
$5,693.07
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,060 · 2020: $282 · 2021: $72.37 · 2023: $258 · 2024: $19.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $278.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $4,180.12 | 2019-2023 | Rexulti |
| Allergan, INC. | $599.53 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $231.79 | 2019-2024 | Trintellix |
| Abbvie INC. | $132.76 | 2021-2023 | Vraylar |
| Bausch Health US, LLC | $68.63 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $64.64 | 2019 | |
| Shire North American Group INC | $52.50 | 2019 | |
| Amgen INC. | $44.54 | 2021 | |
| Alkermes, INC. | $44.47 | 2019 | |
| Lundbeck LLC | $43.54 | 2019-2023 | Rexulti |
| Indivior INC. | $41.81 | 2019 | |
| Neurocrine Biosciences, INC. | $35.22 | 2019-2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $31.81 | 2023 | |
| Neuronetics, INC. | $30.26 | 2019 | |
| Jazz Pharmaceuticals INC. | $14.87 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $14.18 | 2020 | |
| Supernus Pharmaceuticals, INC. | $13.89 | 2023 | Qelbree |
| Arbor Pharmaceuticals, INC. | $13.55 | 2020 | |
| Merck Sharp & Dohme LLC | $12.51 | 2020 | |
| Pernix Therapeutics Holdings, INC. | $11.37 | 2019 | |
| Vanda Pharmaceuticals INC. | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Beck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.